76 related articles for article (PubMed ID: 9252685)
21. K-ras gene mutations and loss of heterozygosity at the p53 gene locus relative to histological characteristics of mucin-producing tumors of the pancreas.
Sakai Y; Yanagisawa A; Shimada M; Hidaka E; Seki M; Tada Y; Harada T; Saisho H; Kato Y
Hum Pathol; 2000 Jul; 31(7):795-803. PubMed ID: 10923915
[TBL] [Abstract][Full Text] [Related]
22. Adenosquamous carcinoma of the pancreas: a clinicopathologic series of 25 cases.
Kardon DE; Thompson LD; Przygodzki RM; Heffess CS
Mod Pathol; 2001 May; 14(5):443-51. PubMed ID: 11353055
[TBL] [Abstract][Full Text] [Related]
23. [Frequency of K-ras mutation in biliary and pancreatic tumors].
Roa JC; Anabalón L; Tapia O; Melo A; de Aretxabala X; Roa I
Rev Med Chil; 2005 Dec; 133(12):1434-40. PubMed ID: 16446870
[TBL] [Abstract][Full Text] [Related]
24. The clinical relevance of ploidy and S-phase fraction determination in salivary gland tumors: a flow cytometric study of 97 cases.
Pinto AE; Fonseca I; Soares J
Cancer; 1999 Jan; 85(2):273-81. PubMed ID: 10023692
[TBL] [Abstract][Full Text] [Related]
25. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
26. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors.
Lindgren P; Bäckström T; Mählck CG; Ridderheim M; Cajander S
Int J Oncol; 2001 Jul; 19(1):31-8. PubMed ID: 11408919
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
28. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas.
Schoedel KE; Finkelstein SD; Ohori NP
Diagn Cytopathol; 2006 Sep; 34(9):605-8. PubMed ID: 16900481
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
[TBL] [Abstract][Full Text] [Related]
30. Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma.
Pinto AE; Silva G; Banito A; Leite V; Soares J
Oncol Rep; 2008 Oct; 20(4):913-9. PubMed ID: 18813835
[TBL] [Abstract][Full Text] [Related]
31. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity.
Shen KL; Yang LS; Hsieh HF; Chen CJ; Yu JC; Tsai NM; Harn HJ
J Surg Oncol; 2000 Jun; 74(2):100-7. PubMed ID: 10914818
[TBL] [Abstract][Full Text] [Related]
32. Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland.
Glas AS; Hollema H; Nap RE; Plukker JT
Cancer; 2002 Apr; 94(8):2211-6. PubMed ID: 12001119
[TBL] [Abstract][Full Text] [Related]
33. K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas.
Bartsch D; Bastian D; Barth P; Schudy A; Nies C; Kisker O; Wagner HJ; Rothmund M
Ann Surg; 1998 Jul; 228(1):79-86. PubMed ID: 9671070
[TBL] [Abstract][Full Text] [Related]
34. Chromosome abnormality in solid and cystic tumor of the pancreas.
Matsubara K; Nigami H; Harigaya H; Baba K
Am J Gastroenterol; 1997 Jul; 92(7):1219-21. PubMed ID: 9219805
[TBL] [Abstract][Full Text] [Related]
35. Papillary cystic tumors of the pancreas. Assessment of their malignant potential.
Nishihara K; Nagoshi M; Tsuneyoshi M; Yamaguchi K; Hayashi I
Cancer; 1993 Jan; 71(1):82-92. PubMed ID: 8416730
[TBL] [Abstract][Full Text] [Related]
36. The beta form of the estrogen receptor is predominantly expressed in the papillary cystic neoplasm of the pancreas.
Morales A; Duarte-Rojo A; Angeles-Angeles A; Mery CM; Ruíz-Molina JM; Díaz-Sánchez V; Robles-Díaz G
Pancreas; 2003 Apr; 26(3):258-63. PubMed ID: 12657952
[TBL] [Abstract][Full Text] [Related]
37. [A clinicopathologic study on eight cases of cystic and solid tumors of pancreas].
Meng Y; Yu J; Kang X; Duan W; Zheng J; Yao L; Hu M; Yang D
Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):409-13. PubMed ID: 11869552
[TBL] [Abstract][Full Text] [Related]
38. Type II estrogen receptors in the papillary cystic tumor of the pancreas.
Carbone A; Ranelletti FO; Rinelli A; Vecchio FM; Lauriola L; Piantelli M; Capelli A
Am J Clin Pathol; 1989 Nov; 92(5):572-6. PubMed ID: 2816810
[TBL] [Abstract][Full Text] [Related]
39. Correlation between proliferating index and prognostic factors in papillary cystic tumors of the pancreas.
Cho NH; Go JH; Jung SH; Jung WH; Lee KK
J Korean Med Sci; 1995 Oct; 10(5):342-51. PubMed ID: 8750060
[TBL] [Abstract][Full Text] [Related]
40. High proportion of mutant K-ras gene in pancreatic juice of patients with pancreatic cystic lesions.
Tateishi K; Tada M; Yamagata M; Isayama H; Komatsu Y; Kawabe T; Shiratori Y; Omata M
Gut; 1999 Nov; 45(5):737-40. PubMed ID: 10517912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
